KIP Medical

📍 Jerusalem, Israel🗓 Founded 2020👥 1 employees💰 Last funded Dec 2020
KIP Medical is focused on research and development of an innovative plant-derived solution to treat patients with various pathological conditions involving dysregulation of the immune system, such as autoimmune diseases and transplanted organ rejection, increased activity of the immune system caused by inflammation and tissue damage, and more. KIP Medical is uniquely positioned to address the unmet medical needs of enhancing the control of the immune system in pathological immune disorders. Currently, we are focused specifically on developing a novel drug that promises to innovate the therapy of dry mouth syndrome and other inflammatory conditions. KIP Medical was born out of the collaboration between Hadassah Medical Center, Prof. Reuven Or, Dr. Osnat Hazan and Pollen Innovation Ltd, an Israeli-based investment firm focused on accelerating disruptive innovations and trends that enhance quality of life and contribute to a better and healthier world.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in KIP Medical?
KIP Medical has 1 investors on record on gritt.io, including 1 early-stage backers.
When did KIP Medical last raise funding?
The most recent investment in KIP Medical recorded on gritt.io was in December 2020.
When was KIP Medical founded?
KIP Medical was founded in 2020.
What industry is KIP Medical in?
KIP Medical operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is KIP Medical based?
KIP Medical is headquartered in Jerusalem, Israel.